Rehabilitation program for women with scleroderma
Physical Rehabilitation in Women With Scleroderma: Effects on Pulmonary Function, Lung Ultrasound, Muscle Function, Hand Functional, Functional Capacity, and Quality of Life
NA · Centro Universitário Augusto Motta · NCT05041868
This study tests a home rehabilitation program to see if it can help women with scleroderma improve their strength and quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | Female |
| Sponsor | Centro Universitário Augusto Motta (other) |
| Locations | 1 site (Rio De Janeiro) |
| Trial ID | NCT05041868 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effects of a therapist-oriented home rehabilitation program on functional capacity and quality of life in women over 18 years with systemic sclerosis (scleroderma). Participants will undergo a three-month rehabilitation program, with assessments conducted before and after the intervention using various functional and quality of life measures. The focus is on improving hand function, peripheral muscle strength, and pulmonary function through tailored exercises. The study aims to address the significant functional limitations faced by this population due to the disease's systemic effects.
Who should consider this trial
Good fit: Ideal candidates for this study are women over 18 years old diagnosed with scleroderma who are clinically stable.
Not a fit: Patients with cognitive impairments, uncontrolled hypertension, or significant limitations due to other health issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the functional capacity and quality of life for women suffering from scleroderma.
How similar studies have performed: While there is limited research specifically on rehabilitation for scleroderma, similar approaches in chronic disease management have shown promise in improving patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with Scleroderma, older than 18 years * Clinical stability * Signature of the Informed Consent Term (TCLE) Exclusion Criteria: * Patients with inability to perform the Glittre Activities of Daily Living test * Patients who have cognitive impairment by mini mental state examination (MEEN). * Abandonment of treatment of scleroderma during the application of the protocol. * Uncontrolled hypertension (\> 180/100 mmHg with medication use) * Use of psychotropic drugs * Any significant limitations due to osteoarthropathy * History of surgery in the previous six months with exercise restriction * IPAQ with very active classification
Where this trial is running
Rio De Janeiro
- Centro Universitário Augusto Motta — Rio De Janeiro, Brazil (RECRUITING)
Study contacts
- Study coordinator: Samantha Alegria, MsC
- Email: s.gomesdealegria13@gmail.com
- Phone: +55 (21) 992936572
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Scleroderma, System, Sclerosis, Muscle Strain, Physical Disability, Quality of Life, Exercise, Physical Therapy